CATALYST DOSSIER · UPDATED 2026-11-09
$SYK
biotech · convergence -9 · conviction WATCH
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $SYK?
Quantitative
Revenue (CY2026Q2) : $6.59B (+9.4% YoY)
Net Income (CY2026Q2) : $1.28B (+44.3% YoY)
Net Margin (CY2026Q3) : 11.6%
Catalysts
Multi-spoke convergence : 10 convergent signals fired: finra_short, oge_exec, healthcare_extras, auto_macro_adp_payrolls, auto_macro_banrep_colombia
Risks
Position-sizing discipline : Conviction WATCH (-9 score) — size accordingly; no specific catalyst-fade risk flagged
Bear case
Squeeze unwind : Short interest can compress before retail catches the move — entry timing critical
Sympathy basket (cerebro)
MNDY via tech r=+0.98 sympathetic (score 35)
QBTS via tech r=+0.98 sympathetic (score 24)
NVDA via semis r=+0.88 sympathetic (score 32)
DIOD via semis r=+0.88 sympathetic (score 18)
SKYD via comms r=+0.70 sympathetic (score 21)
UNIT via comms r=+0.70 sympathetic (score 17)
Signals Firing
finra_short oge_exec healthcare_extras auto_macro_adp_payrolls auto_macro_banrep_colombia auto_macro_bls_employment auto_macro_durable_goods auto_macro_fx_rates auto_macro_options_gex auto_macro_yield_curve
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-10-30 sec_top_gappers +5.5% +5.1% ✓ hit 2026-10-30 sec_top_moat_emerging +5.5% +5.1% ✓ hit
Lifetime: 2/2 wins · hit-rate 100.0% on +2% intraday
Sympathy Basket MNDY via tech · score 35 QBTS via tech · score 24 NVDA via semis · score 32 DIOD via semis · score 18 SKYD via comms · score 21 UNIT via comms · score 17
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.